Genine Winslow

Company: Chameleon Biosciences

Job title: CEO

Seminars:

PANEL DISCUSSION: Where are the Biggest Bottlenecks for Gene Therapy Immunogenicity & Which Approaches are Showing Most Promise (and Feasibility)? 2:30 pm

Actively minimizing immunogenic responses How close are we to redosing? Widening patient eligibility in relation to antibody positivity Exploring innovative vector modificationsRead more

day: Post-Conference Discussion Day - Track A

Investigating the Promise of Redosing in Gene Therapy with EVADER 10:00 am

Moving away from the ‘one and done’ paradigm Understanding of underlying biology of immune response continues to increase Defining optimal dosing regimens with Chameleon’s EVADER technologyRead more

day: Post-Conference Discussion Day - Track A